GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Bioxyne Ltd (ASX:BXN) » Definitions » Gross-Profit-to-Asset %

Bioxyne (ASX:BXN) Gross-Profit-to-Asset % : 36.06% (As of Dec. 2023)


View and export this data going back to 2000. Start your Free Trial

What is Bioxyne Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Bioxyne's annualized Gross Profit for the quarter that ended in Dec. 2023 was A$4.04 Mil. Bioxyne's average Total Assets over the quarter that ended in Dec. 2023 was A$11.22 Mil. Therefore, Bioxyne's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 was 36.06%.


Bioxyne Gross-Profit-to-Asset % Historical Data

The historical data trend for Bioxyne's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioxyne Gross-Profit-to-Asset % Chart

Bioxyne Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 25.34 33.26 35.54 45.45 18.41

Bioxyne Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 51.80 34.03 31.74 23.08 36.06

Competitive Comparison of Bioxyne's Gross-Profit-to-Asset %

For the Packaged Foods subindustry, Bioxyne's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bioxyne's Gross-Profit-to-Asset % Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Bioxyne's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Bioxyne's Gross-Profit-to-Asset % falls into.



Bioxyne Gross-Profit-to-Asset % Calculation

Bioxyne's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Jun. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Jun. 2023 )/( (Total Assets (A: Jun. 2022 )+Total Assets (A: Jun. 2023 ))/ count )
=1.898/( (2.923+17.693)/ 2 )
=1.898/10.308
=18.41 %

Bioxyne's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Dec. 2023 )/( (Total Assets (Q: Jun. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=4.044/( (17.693+4.737)/ 2 )
=4.044/11.215
=36.06 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is two times the semi-annual (Dec. 2023) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Bioxyne Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Bioxyne's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Bioxyne (ASX:BXN) Business Description

Traded in Other Exchanges
N/A
Address
50 Clarence Street, Suite 506, Level 5, Sydney, NSW, AUS, 2000
Bioxyne Ltd is an Australian life science and health products company. The company is engaged in the development, manufacture, and distribution of consumer dietary supplements based on the proprietary probiotic strain of Lactobacillus Fermentum PCC. Some of its products include Breathe life Science, Dr Watson, BLS Clinics, Mirai Solution, CanXChange etc. It operates in three segments: wholesale sales, Plant based and direct sales. The majority of the revenue is generated from Plant based in the United Kingdom, Europe and Japan.

Bioxyne (ASX:BXN) Headlines

No Headlines